Nocopi Technologies Appoints Debra Glickman as Chief Financial Officer and Announces the Retirement of Rudy Lutterschmidt
June 21, 2023 07:30 ET
|
Nocopi Technologies, Inc.
KING OF PRUSSIA, Pa., June 21, 2023 (GLOBE NEWSWIRE) -- Nocopi Technologies, Inc. (OTC Pink: “NNUP”), a developer of specialty reactive inks, announced that on June 15, 2023, Rudolph A....
Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patent in Japan
June 13, 2023 07:00 ET
|
Salipro Biotech AB
Salipro Biotech obtains granted patent in Japan, protecting its proprietary Salipro® platform technology to enable the development of therapeutics against challenging drug targets, including GPCRs,...
European Patent Office to Grant ZyVersa Therapeutics’ Patent Application for Cholesterol Transport Mediator™ VAR 200 for Use in Patients with Diabetic Nephropathy/Diabetic Kidney Disease
June 06, 2023 09:07 ET
|
ZyVersa Therapeutics
Cholesterol Transport Mediator™ VAR 200 is in development to reduce renal cholesterol and lipid accumulation that damages the kidneys' filtration system in patients with glomerular diseases, including...
Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform
June 06, 2023 04:06 ET
|
Anaqua
BOSTON, June 06, 2023 (GLOBE NEWSWIRE) -- Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced that global medical technology company...
Getinge wählt zentralisierte IP-Management-Plattform von Anaqua
June 06, 2023 04:06 ET
|
Anaqua
BOSTON und MÜNCHEN, June 06, 2023 (GLOBE NEWSWIRE) -- Anaqua, der führende Technologieanbieter für Innovation und Management von geistigem Eigentum (IP), gab heute bekannt, dass sich das...
AB Science announces issuance of a Canadian patent for masitinib in the treatment of ALS with protection until 2037
June 01, 2023 12:01 ET
|
AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A CANADIAN PATENT FOR MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) WITH PROTECTION UNTIL 2037 CANADIAN PATENT COMPLETES...
AB Science annonce la délivrance d’un brevet canadien pour le masitinib dans le traitement de la SLA avec une protection jusqu’en 2037
June 01, 2023 12:01 ET
|
AB Science
PRESS RELEASE AB SCIENCE ANNONCE LA DÉLIVRANCE D'UN BREVET CANADIEN POUR LE MASITINIB DANS LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE (SLA) AVEC UNE PROTECTION JUSQU'EN 2037 CE BREVET...
Fresco Secures US Patent for Proprietary KitchenOS Platform and AI Recipe Engine
May 31, 2023 09:00 ET
|
Fresco
DUBLIN, Ireland, May 31, 2023 (GLOBE NEWSWIRE) -- Fresco, the leading smart kitchen platform for the world’s appliance brands, announced today that it has been granted its first patent on its path...
Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office for Repirinast and the Treatment of CKD
May 31, 2023 07:19 ET
|
Algernon Pharmaceuticals
Vancouver, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical...
Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection
May 08, 2023 09:15 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc....